Draper

Johnson & Johnson operates two core business divisions - Innovative Medicine and MedTech - serving the global healthcare sector. Founded in 1886 and headquartered in the United States, the company employs over 135,000 people worldwide and has maintained a position among the top three pharmaceutical companies globally for more than a decade. Under CEO Joaquin Duato, the organization focuses on developing pharmaceuticals, medical devices, and surgical technologies across eight primary healthcare domains: oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision care. The MedTech division develops and manufactures medical devices and surgical technologies, representing one of the company's two core operational areas. This division's work encompasses instrumentation, robotics integration points, and surgical systems that interface with clinical workflows. The hardware and software systems developed here must meet stringent regulatory requirements while operating reliably in demanding clinical environments. Engineers working on these systems address challenges in precision mechanics, sensor integration, real-time control systems, and human-machine interfaces where safety constraints and edge case handling are critical. The company's technical approach emphasizes science-based innovation with a focus on solving complex healthcare challenges through hardware-software integration. With products reaching billions of people daily, the engineering work involves scaling solutions across diverse regulatory environments and clinical settings worldwide. The organization has operated under its guiding principles document, "Our Credo," for over a century, providing organizational stability while the company pursues development in areas including advanced surgical technologies and medical device systems that require multi-disciplinary engineering expertise.

Vanderlande designs and deploys integrated automation systems for warehousing, airports, and parcel sorting, combining mechanical handling equipment with control software and lifecycle services. Founded in 1949 and now part of the Toyota Automated Logistics Group, the company has installed systems at more than 600 airports worldwide, including 12 of the top 20 by traffic volume. The 2026 acquisition of Siemens Logistics' operations expanded both the deployed base and the company's engineering footprint. With over 11,000 employees across more than 100 countries, Vanderlande operates at the intersection of material handling hardware, real-time control systems, and large-scale integration. The technical domain spans conveyors, sorters, automated storage and retrieval systems, and the software layers that orchestrate them - often interfacing with warehouse management systems and airport operational databases. Control architectures frequently involve Siemens PLCs and proprietary middleware for sequencing, routing, and fault recovery. Edge cases include handling mixed parcel geometries, peak-hour throughput demands in baggage systems, and maintaining uptime across geographically distributed installations. Solutions are tailored per site: an e-commerce fulfillment center demands different sortation logic and scalability than an airport baggage hall with strict regulatory and safety constraints. Deployment cycles are measured in months to years, with commissioning, integration testing, and operator training forming significant engineering effort. Field-proven designs reduce risk, but each installation introduces site-specific challenges - building interfaces, local regulations, and operational workflows that require hardware modifications and software tuning. The emphasis is on lifecycle support: systems are expected to run for decades, so maintainability, spare-parts logistics, and software updates are first-order design considerations rather than afterthoughts.

Astranis is building a new class of satellites - small, powerful satellites for high orbits with the latest in digital processing technology. We designed our first product, MicroGEO, to offer dedicated satellite broadband at the world's lowest cost. Today we have five satellites on orbit, with more than 10 satellites under contract for customers around the world, representing over $1 billion of satellite services sold. What we're doing hasn't been done before. High orbits like geostationary (GEO) are incredibly valuable but technically demanding - the radiation environment would fry normal computer hardware, and getting there requires specialized propulsion. We've solved these problems by building small, radiation-hardened spacecraft that were thought impossible until we built them. We design, manufacture, test, and operate everything out of our headquarters at Historic Pier 70 in San Francisco, a facility that previously built warships and now builds spaceships.

Stryker is a global medical technology company founded in 1941 by Dr. Homer Stryker, operating across 75 countries with $22.6 billion in annual sales as of 2024. The company focuses on three core business segments: MedSurg, Neurotechnology, and Orthopaedics, impacting more than 150 million patients annually through products and services designed to improve patient and healthcare outcomes. With a portfolio spanning surgical technologies, endoscopy systems, neurovascular devices, joint replacement systems, sports medicine solutions, acute care equipment, and healthcare communications infrastructure, Stryker maintains 14,200 patents and invested $1.5 billion in R&D in 2024. The company's technical domains address specific clinical challenges across the surgical and interventional spectrum. In neurotechnology, this includes neurovascular devices for stroke and aneurysm treatment. The orthopaedics division develops joint replacement systems and sports medicine products for reconstructive procedures. MedSurg operations encompass surgical instrumentation, endoscopic visualization systems, and acute care technologies including patient handling and emergency medical equipment. These systems operate in demanding environments - operating rooms, catheterization labs, and acute care settings - where reliability, precision, and integration with existing hospital infrastructure are non-negotiable constraints. What began as a small orthopedic device manufacturer has grown into what the company describes as an industry powerhouse, maintaining operations that span from product development through commercial deployment. The engineering culture emphasizes accountability and performance, with teams working alongside clinical customers to deploy solutions in real-world healthcare settings. Under CEO Kevin Lobo's leadership, the organization maintains headquarters in the United States while supporting a distributed global operation that delivers medical technology systems to healthcare facilities worldwide.

Solenis is a global provider of process and water treatment solutions serving industrial and municipal customers across 160 countries. With a team of 23,000 people and operational roots extending more than 100 years, the company delivers engineering, chemical, and service solutions to industries including pulp and paper, food and beverage, oil and gas, municipal water treatment, and commercial laundry operations. The company applies chemistry and digital technologies to address water treatment and process optimization challenges at scale. The company's operational model centers on daily field presence at customer sites - paper mills, municipal water treatment facilities, and industrial plants - where technical teams work directly on process problems. This hands-on approach combines chemical treatment systems with on-site engineering support to address water quality, process efficiency, and operational constraints. Solenis positions its solutions around sustainability objectives, helping customers optimize water usage and meet environmental performance targets through chemistry-based treatment processes and digital monitoring technologies. For engineers, the work involves practical problem-solving in industrial environments where water chemistry, process control, and system integration intersect. The company's scope spans multiple industrial verticals, each with distinct treatment requirements and operational constraints. Field service roles require translating chemical treatment theory into deployed solutions that function reliably in production environments, working within the physical and economic constraints of existing industrial infrastructure.

Orbem exists to shed light on the world's toughest challenges by combining rapid magnetic resonance imaging with advanced deep learning algorithms. By making MRI technology fast, accessible, and simple, Orbem unlocks hidden biological insights that were previously unattainable at industrial scale. Their AI-powered imaging platform, the Genus product family, delivers non-destructive insights for everything from poultry and fruits to nuts and human health applications. Founded in 2019 as a spin-off from the Technical University of Munich, Orbem has grown to over 200 team members across offices in Munich and Houston. The company's mission-driven approach addresses critical global challenges: reducing the 1.25 billion tonnes of produce lost annually between harvest and retail, enabling sustainable food production for 10 billion people by 2050, and transforming disease detection. By providing radical transparency through inside-out intelligence, Orbem champions ethical production while building technology that serves both business value and planetary health.